Dockets
Recently active federal rulemakings, soonest-closing first.
Open for comment
EPA ▾
All agenciesACF (17)AID (1)AMS (52)APHIS (64)ARS (1)ASC (10)ATBCB (6)ATF (31)ATR (1)ATSDR (3)BIA (1)BIS (13)BLM (18)BLS (3)BOEM (57)BSC (3)BSEE (13)CCC (1)CDC (83)CDFI (2)CEQ (2)CFPB (46)CFTC (23)CISA (15)CMS (216)CNCS (24)COE (3)COLC (5)CPPBSD (2)CPSC (41)CSB (1)DARS (22)DEA (164)DEPO (1)DHS (50)DOC (1)DOD (110)DOE (60)DOI (7)DOJ (11)DOL (2)DOS (37)DOT (598)EAB (1)EAC (10)EBSA (19)ED (131)EDA (1)EEOC (1)EERE (19)
- 0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- New Biochemical Active Ingredient; Sea Lamprey Pheromone, 3-ketopetromyzonol-24-sulfateEPANonrulemaking0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- 4-chlorophenoxyacetic acid (4-CPA) – Combined Work Plan, Summary Document, and Proposed Interim Registration Review Decision. Case Number 2115.EPANonrulemaking0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
